Abstract
This case of a 10-year-old girl herein presented is one of the earliest to report safe and effective use of cariprazine, a metabolic-friendly agent, targeting the behavioral facets in ASD. This might open new treatment venues in such complicated clinical scenarios.
Keywords
Access This Article
Choose an access option below to view the full article.
How to Cite
Ahmed Naguy, Saxby Pridmore, Bibi Alamiri. Cariprazine for Autism—A Case Report. Psychopharmacology Bulletin.
2026/06/05; 56(3):169-172.
https://doi.org/10.64719/pb.18549
